Apr 24, 2008 - Dako’s new set of ready-to-use antibodies, Flex RTU, is the largest and most clinically relevant antibody portfolio on the market. It has been developed for diagnosis of the most common types of cancer (breast, colon, lung, prostate, melanoma, etc.). With the number of patients waiting for cancer diagnosis continually on the rise, Dako works to provide pathology laboratories with workflow solutions linking knowledge, reagents, instruments and software for fast and accurate answers... Dako’s Press Release -
